TY - JOUR
T1 - Disparities in Current Pulmonary Embolism Management and Outcomes
T2 - A Scientific Statement from the American Heart Association
AU - American Heart Association Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Peripheral Vascular Disease
AU - Takahashi, Edwin A.
AU - Sista, Akhilesh K.
AU - Addison, Daniel
AU - Bikdeli, Behnood
AU - Bishay, Vivian L.
AU - Gu, Sue
AU - Hood, Maureen N.
AU - Litmanovich, Diana
AU - Misra, Sanjay
AU - Reddy, Gautham
AU - De Jesus Perez, Vinicio A.
AU - Hadidi, Niloufar N.
AU - McGiffin, David Charles
AU - Singer, Adam J.
AU - Vedantham, Suresh
N1 - Publisher Copyright:
© 2025 American Heart Association, Inc.
PY - 2025/4/15
Y1 - 2025/4/15
N2 - Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism affects individuals from all demographics, the incidence of pulmonary embolism is higher among people from certain racial groups, reproductive-age women compared with age-matched men, and transgender people taking estrogen hormones. Furthermore, disparities may exist in the diagnosis or management strategies of pulmonary embolism associated with race, ethnicity, sex, or socioeconomic status, which may correlate with poorer downstream outcomes, including recurrent pulmonary embolism, chronic thromboembolic pulmonary hypertension, or short- or long-term mortality. This scientific statement summarizes disparities in diagnosis, treatment strategies, and outcomes related to pulmonary embolism, and reviews approaches to create equitable pulmonary embolism care and address the knowledge gaps in the literature.
AB - Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism affects individuals from all demographics, the incidence of pulmonary embolism is higher among people from certain racial groups, reproductive-age women compared with age-matched men, and transgender people taking estrogen hormones. Furthermore, disparities may exist in the diagnosis or management strategies of pulmonary embolism associated with race, ethnicity, sex, or socioeconomic status, which may correlate with poorer downstream outcomes, including recurrent pulmonary embolism, chronic thromboembolic pulmonary hypertension, or short- or long-term mortality. This scientific statement summarizes disparities in diagnosis, treatment strategies, and outcomes related to pulmonary embolism, and reviews approaches to create equitable pulmonary embolism care and address the knowledge gaps in the literature.
KW - AHA Scientific Statements
KW - delivery of health care
KW - pulmonary embolism
KW - risk
UR - https://www.scopus.com/pages/publications/105000827300
U2 - 10.1161/CIR.0000000000001306
DO - 10.1161/CIR.0000000000001306
M3 - Review article
C2 - 40109246
AN - SCOPUS:105000827300
SN - 0009-7322
VL - 151
SP - e944-e955
JO - Circulation
JF - Circulation
IS - 15
ER -